Volume 4 (2022)
Volume 3 (2021)
Volume 2 (2020)
Volume 1 (2019)
Keywords = molecular docking
Number of Articles: 6
1. Honey and royal jelly natural products as possible antiviral nominations to combat SARS-CoV-2 main protease
Volume 4, Issue 6 , June 2022, , Pages 567-579
Abstract
The new type of coronavirus called Severe Acute Respiratory Corona Virus-2 (SARS-CoV-2) has spread over the globe, left the world in lockdown, and taken more lives globally. Hence, ... Read More2. A computational study at blocking probability of the SARS-CoV-2 spike protein through the binding of cellular receptors
Volume 3, Issue 6 , June 2021, , Pages 369-382
Abstract
In this paper, the SARS-CoV-2 spike encoding gene sequences were analyzed to find the structural homology of S proteins. The S protein of SARS-CoV-2 was obtained from homology modeling ... Read More3. In silico study of the active components (17α-ethinyl estradiol and segesterone acetate) of annovera as a novel vaginal contraceptive system by docking of their binding to estrogen and progesterone receptors
Volume 2, Issue 2 , February 2020, , Pages 234-246
Abstract
The main purpose of the present research article is the docking analysis of active substances of annovera (segesterone acetate and ethinyl estradiol) with progesterone and estrogen ... Read More4. Molecular docking and druggability studies of terpenoid-derived metabolites from marine sponges as IL-17A inhibitors
Volume 1, Issue 5 , September and October 2019, , Pages 419-432
Abstract
In this study, physicochemical properties of 49 compounds extracted from anti-inflammatory sponge species with the aim of ADMET test and Lipinski rule of five have been determined. ... Read More5. Modeling and interactions analysis of the novel antagonist agent flibanserin with 5-hydroxytryptamine 2A (5-HT2A) serotonin receptor as a HSDD treatment in premenopausal women
Volume 1, Issue 3 , May and June 2019, , Pages 290-300
Abstract
Flibanserin is a novel antagonist small molecule to treat the hypoactive sexual desire disorder (HSDD) in the premenopausal women. The present article is related to the structural and ... Read More6. Synthesis and molecular docking of novel N-((2-chloroquinolin-3-yl) methylene)-4-methylbenzenamine derivatives as anti-HIV-1 reverse transcriptase inhibitors
Volume 1, Issue 2 , March and April 2019, , Pages 125-133